Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.61% |
| 2 | Healthcare | 12.42% |
| 3 | Financials | 11.99% |
| 4 | Consumer Staples | 9.6% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
McCormick & Company Non-Voting
MKC
$14.6B
| $19.3M | 0.03% |
385,600
+44,600
| +13% | +$2.26M |
|
727
Insulet
PODD
$10.2B
| $19.3M | 0.03% |
470,400
-150,492
| -24% | -$5.95M |
|
|
MTSC
728
DELISTED
MTS Systems Corp
MTSC
| $19.2M | 0.03% |
417,318
-13,500
| -3% | -$636K |
|
729
Shutterstock
SSTK
$217M
| $19.2M | 0.03% |
300,900
+82,000
| +37% | +$4.71M |
|
730
Pinnacle West Capital
PNW
$12.2B
| $19.1M | 0.03% |
251,900
-167,000
| -40% | -$13M |
|
731
TransUnion
TRU
$15.5B
| $19.1M | 0.03% |
554,100
+62,600
| +13% | +$2.1M |
|
732
Culp Inc
CULP
$43.2M
| $19.1M | 0.03% |
640,729
-2,371
| -0.4% | -$70K |
|
|
FSP
733
Franklin Street Properties
FSP
$46.4M
| $19.1M | 0.03% |
1,513,900
+124,000
| +9% | +$1.56M |
|
|
BEAT
734
DELISTED
BioTelemetry, Inc.
BEAT
| $19.1M | 0.03% |
1,027,200
+103,568
| +11% | +$1.95M |
|
|
ANAT
735
DELISTED
American National Group, Inc. Common Stock
ANAT
| $19M | 0.03% |
156,000
+6,300
| +4% | +$727K |
|
|
XXIA
736
DELISTED
Ixia
XXIA
| $19M | 0.03% |
1,520,220
-162,285
| -10% | -$1.86M |
|
|
UHT
737
Universal Health Realty Income Trust
UHT
$573M
| $19M | 0.03% |
300,800
+38,000
| +14% | +$2.29M |
|
|
PE
738
DELISTED
PARSLEY ENERGY INC
PE
| $19M | 0.03% |
565,600
-199,100
| -26% | -$6.23M |
|
739
H&R Block
HRB
$6.76B
| $18.9M | 0.03% |
816,400
-33,900
| -4% | -$793K |
|
740
Healthcare Realty
HR
$6.58B
| $18.9M | 0.03% |
579,100
+337,828
| +140% | +$11.2M |
|
|
TCO
741
DELISTED
Taubman Centers Inc.
TCO
| $18.9M | 0.03% |
253,800
-92,100
| -27% | -$7.11M |
|
|
HMSY
742
DELISTED
HMS Holdings Corp.
HMSY
| $18.9M | 0.03% |
851,600
-60,112
| -7% | -$1.26M |
|
743
AMC Entertainment Holdings
AMC
$2.35B
| $18.8M | 0.03% |
60,620
+22,120
| +57% | +$6.63M |
|
744
United Rentals
URI
$69.7B
| $18.8M | 0.03% |
+240,023
| New | +$18.4M |
|
|
PHH
745
DELISTED
PHH Corporation
PHH
| $18.8M | 0.03% |
1,297,900
+366,500
| +39% | +$5.38M |
|
746
Stepan Co
SCL
$1.48B
| $18.7M | 0.03% |
257,300
+21,800
| +9% | +$1.46M |
|
|
GTY
747
Getty Realty Corp
GTY
$2.05B
| $18.7M | 0.03% |
780,386
-26,500
| -3% | -$613K |
|
|
CPE
748
DELISTED
Callon Petroleum Company
CPE
| $18.7M | 0.03% |
118,919
+59,290
| +99% | +$7.84M |
|
749
TechnipFMC
FTI
$30.1B
| $18.7M | 0.03% |
845,645
-1,353,542
| -62% | -$27.4M |
|
750
Enanta Pharmaceuticals
ENTA
$391M
| $18.7M | 0.03% |
701,400
+549,200
| +361% | +$12.8M |
|
Similar funds
Jim Simons's Q3 2016 Portfolio in Review
As of Q3 2016, Jim Simons held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Jim Simons's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Jim Simons added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Jim Simons's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Jim Simons fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Jim Simons's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Jim Simons opened 414 new positions and closed 416 in Q3 2016.
- Jim Simons's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.